Abstract
In a 6-month prospective study designed to retard the aging process, we examined the effects of comprehensive lifestyle modifications in 52 participants aged 31 to 78 years, who were free of clinically overt disease. The group adhered to a low-fat vegetarian diet supplemented with antioxidant nutrients, engaged in regular aerobic exercise (power-walking or jogging), and received motivational support. Statistical analysis of objective data shows a trend of optimization of weight and lipid values. Overall, the group lost an average of 2.95 kg, or 4.4% of starting weight; total cholesterol (TC) decreased 7.7%; LDL-C, 12%; and TC/HDL-C ratio, 9%. Analysis by age and gender shows no significant differences in trends. When grouped by objective parameter, maximal effect is found in those with greatest deviation from a normal value at baseline. Subjective assessments showed significant improvement in energy levels and physiological functioning. Although more well-defined studies are needed, we conclude that lifestyle modifications can optimize health status and level of physiologic functioning, and may be instituted by adults of all age groups with prior medical approval.
Similar content being viewed by others
References
Kannel WB, Wilson PW.: Efficacy of lipid profiles in prediction of coronary disease. Am Heart J. 1992;124:768–774.
Rose G.: Strategy of prevention: lessons from cardiovascular disease. Br Med J. 1981; 282: 1847–51.
Ferrini RL, Edelstein SL, Barrett-Connor E.: Factors associated with health behavior change among residents 50 to 96 years of age in Rancho Bernardo, California. Am J Prev Med. 1994;10:26–30.
McGinnis JM.: Prevention in 1989: the state of the nation. Am J Prev Med. 1990;6:1–5.
Salonen JT, Salonen R, Seppanen K, et al.: Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. Br Med J. 1991;302:756–760.
Kok FJ.: Antioxidants and risk of myocardial infarction. Acta Cardiol. 1993;48:456–7.
Rimm EB, Stampfer MJ, Ascherio A, et al.: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450–1456.
Stampfer MJ, Hennekens CH, Manson JE, et al.: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444–9.
The Carter Center of Emory University, Health Policy Consultation. Closing the gap: health policy project interim summary. 1984; B99,B34,B20.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015–3023.
Kronhausen E, Kronhausen P, Demopoulos HB.: Formula for Life. William Morrow and Co. New York, 1989:95.
Gaby SK, Singh VN.: Vitamin C in Vitamin Intake and Health: A Scientific Review, Gaby SK, Bendich A, Singh V, Machlin L (eds). Marcel Dekker, New York, 1991.
Bland J.: The nutritional effects of free radical pathology. In: 1986/A Year in Nutritional Medicine Monograph. Keats Publishing Inc., New Canaan, CT.
Vitamin E strengthens the immune system in elderly patients. Drug Topics. February 18, 1991, 135: 38.
Null G, Feldman M.: Reverse the Aging Process Naturally. New York: Random House Inc; 1993. p 269.
Hocman G.: Chemoprevention of cancer: selenium. Int J Biochem. 1988;20:123–132.
Bendrich A.: Antioxidant micronutrients and immune responses. In: Bendich A, Chandra RK, eds: Micronutrients and Immune Function. Annals New York Academy of Sciences. New York, 1990.
Cody V, Middleton E, Harborne JB.: Plant Flavonoids in Biology and Medicine — Biochemical, Pharmacological, and Structure-Activity Relationships. Alan R. Liss, New York, NY. 1986.
Havsteen B.: Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 1983;32:1–148.
Middleton E.: The flavonoids. Trends Pharmaceut Sci. 1984;5:335–338.
Null G.: Change Your Life Now. Deerfield Beach, Fla: Health Communications, Inc; 1993:1–182.
Castelli WP, Anderson K.: A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med. 1986;80(suppl 2A):23–32.
National Health Laboratories; source: Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148: 36–69.
Frick MH, Elo O, Haapa K, et al.: Helsinki Heart Study Primary Prevention Trial with gemfibrozil in middle-aged men with dyslipidemia. N EnglJ Med. 1987;317:1237–1244.
Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial Results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984; 251:365–374.
Hellenius ML, de Faire U, Berglund B, Hamsten A, Krakau I.: Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors. Atherosclerosis. 1993; 103:81–91.
Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, et al.: Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med. 1988;319:1173–9.
Paffenbarger RS Jr, Hale WE.: Work activity and coronary heart mortality. N Engl J Med. 1975; 292:545–550.
Morris JN, Everitt MG, Pollard R, et al.: Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet. 1980;2:1207–1210.
Dufaux B, Assmann G, Hollmann W.: Plasma lipoproteins and physical activity: a review. IntJ Sports Med. 1982;3:123–136.
Mersy DJ.: Health benefits of aerobic exercise. Postgrad Med. 1991;90:103–112.
Jennings G, Nelson L, Nestel P, et al.: The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation. 1986;73:30–40.
Superko HR.: Exercise training, serum lipids, and lipoprotein particles: is there a change threshold? Med Sci Sports Exerc 1991;23:677–85.
Shepard RJ.: Nutritional benefits of exercise. J Sports Med Phys Fitness. 1989;29:83–90.
Reid CM, Dart AM, Dewar EM, Jennings GL.: Interactions between the effects of exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure in overweight subjects. J Hypertens 1994; 12:291–301.
Salonen JT.: The role of lipid peroxidation, antioxidants and pro-oxidants in atherosclerosis. Acta Cardiol. 1993;48:457–459.
Maxwell SR.: Can anti-oxidants prevent ischaemic heart disease? J Clin Pharm Ther. 1993; 18: 85–95.
Singh RB, Niaz MA, Gosh S, Singh R, Rastogi SS.: Effect on mortality of adding fruits and vegetables to a prudent diet in the Indian experiment of infarct survival (IEIS). J Am Coil Nutr. 1993; 12:255–261.
Maxwell SR, Jakeman P, Thomason H, Leguen C, Thorpe GH.: Changes in plasma antioxidant status during eccentric exercise and the effect of vitamin supplementation. Free Radic Res Commun. 1993; 19:191–202.
Ornish D, Brown SE, Scherwitz LW, et al.: Can lifestyle changes reverse coronary heart disease? Lancet. 1990;336:129–133.
Levy RI, Brensike JF, Epstein SE, et al.: The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease. Circulation. 1984;69:325–337.
Blankenhorn DW, Nessim SA, Johnson RL, et al.: Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987;257:3233–3240.
Brown G, Albers JJ, Fisher LD, et al.: Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323: 1289–1295.
Levy RI, Treondle AJ, Fattu JM.: A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin. Circulation. 1993;87(4 Suppl):III-45–III-53.
Hay JW, Wittels EH, Gotto Jr, AM.: An economic evaluation of Iovastatin for cholesterol lowering and coronary artery disease reduction. Am J Cardiol. 1991;67:789–796.
Kinlay S, O’Connell D, Evans D, Halliday J.: A new method of estimating cost effectiveness of cholesterol reduction therapy for prevention of heart disease. PharmacoEconomics. 1994;5:238–248.
Sempos CT, Cleeman JI, Carroll MD, et al.: Prevalence of high blood cholesterol among US adults: an update based on guidelines from the second Report of the National Cholesterol Education Program Adult Treatment Panel. JAMA. 1993;269:3009–3014.
Ramsey LE, Yeo WW, Jackson PR.: Dietary reduction of serum cholesterol concentration: time to think again. Br Med J. 1991;303:953–057.
Kannel WB.: Low high-density lipoprotein cholesterol and what to do about it. Am J Cardiol. 1992; 70:810–814.
Author information
Authors and Affiliations
About this article
Cite this article
Null, G., Feldman, M. Comprehensive lifestyle interventions in the community: A preliminary analysis. AGE 19, 91–100 (1996). https://doi.org/10.1007/BF02434088
Issue Date:
DOI: https://doi.org/10.1007/BF02434088